View external media coverage about Appriss to learn what’s happening.
For media inquiries, please visit our inquiries page.
Yale New Haven Health and Yale School of Medicine have launched a partnership with the State of Connecticut and Appriss Health in an innovative effort to combat the opioid overdose crisis.
Loss prevention departments have, for some time, successfully examined risk flags within point-of-sale (POS) transactions to identify exceptions that may indicate theft or loss. These risk flags, many of which decrease potential revenue, are…
Appriss Health’s PMP Gateway Solution Integrates INSPECT Information in Real-time Directly into EHRs and Pharmacy Management Systems to Serve as a Critical Clinical Decision Support Tool for All Indiana Prescribers and Dispensers in Workflow
Indiana will integrate prescription drug data into EHRs at hospitals and physician practices across the state, Gov. Eric Holcomb announced on Thursday. The decision follows a growing trend among states across the country to make opioid…
Appriss, a 600-employee company in Louisville, is working to mitigate a U.S. opioid crisis blamed for more than 20,000 fatal overdoses a year—33,000 when heroin-related deaths are included—and $79 billion in annual response costs and lost…
This country is in the midst of an opioid overdose epidemic as millions of Americans struggle with pain and addiction—according to the Centers for Disease Control and Prevention, opioids killed more than 28,000 people in 2014, more than any year…
Six-hospital Deaconess Health System, which serves southwest Indiana, is monitoring patients who are being prescribed opioids to identify those who may be at risk for drug abuse.
Sometimes it’s hard to get in to see a doctor when you need to, or to get your children an appointment; not to mention the cost can be difficult to swallow. But if you work at one Louisville company, you can just walk down the hall from your…
A federal commission advises POTUS to encourage more health data exchange between PDMPs and hospitals for improved prescription drug monitoring.